Mizuho downgraded Kala Bio (KALA) to Neutral from Outperform with a price target of $1.50, down from $30. The firm cites yesterday’s negative Phase 2 results for the company’s lead asset KPI-012 for the downgrade. Mizuho is “very disappointed” by the data and has been unable to connect with management. The analyst removed KPI-012 Kala’s model and downgraded the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KALA: